Event News & Resources

Anton joins Neuro-Bio!

Anton joins Neuro-Bio!

Neuro-Bio welcomes Anton Shmelev as part of the team. Anton hopes to apply his experience in the areas of protein misfolding, receptor trafficking, as well as general protein science and molecular biology into the field of the Alzheimer’s research conducted at...

read more
Neuro-bio’s seminal paper has been accepted.

Neuro-bio’s seminal paper has been accepted.

We are delighted to announce that our seminal paper A novel process driving Alzheimer’s validated in a mouse model: therapeutic potential’ has been accepted by the peer-reviewed journal  Alzheimer's & Dementia: Translational Research & Clinical...

read more
Neuro-Bio at the Rosalind Franklin institute.

Neuro-Bio at the Rosalind Franklin institute.

Great success for Neuro-bio's CEO, Susan Greenfield at the Rosalind Franklin Institute on Thursday 27.01. She talked about the assets that the company is currently working on and had the chance to talk and meet the audience. The Neuro-bio's team was there to support...

read more
Covid-19 update

Covid-19 update

Considering the increase spreading of the virus Covid-19, Neuro-Bio Ltd is performing routine lateral flow tests at least once a week to its employees. This will make sure that everyone at Neuro-Bio is safe and monitored and will allow visitors to come on site without...

read more
NeuroBio logo

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Neuro-Bio

You have Successfully Subscribed!